European equities traded in the US as American depositary receipts kicked off the week on strong note late Monday morning, surging 1.83% higher to 1,442.61 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and biopharmaceutical company Genfit (GNFT), which rose 6.3% and 6% respectively. They were followed by accommodations booking site trivago (TRVG) and financial services company ING Groep (ING), which increased 5.6% and 5.3% respectively.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and biotech firm Evaxion Biotech (EVAX), which dropped 8.5% and 6.7% respectively. They were followed by internet browser company Opera (OPRA) and semiconductor company Sequans Communications (SQNS), which were down 2% and 1.7% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which advanced 6.3% and 3.7% respectively. They were followed by biopharmaceutical company TC Biopharm (TCBP) and mining company BHP Group (BHP), which were up 3.6% and 3.1% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Bicycle Therapeutics (BCYC), which fell 4% and 2.4% respectively. They were followed by biopharmaceutical companies NuCana (NCNA) and Verona Pharma (VRNA), which lost 2.1% and 1.6% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。